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 Abstract 
Background: There is a lack of knowledge regarding obstructive sleep apnea (OSA) prevalence 
in older men from the general population. The aim of this cross-sectional study was to determine 
the prevalence of OSA in 71-year old men derived from the general population in Gothenburg, 
Sweden. Moreover, to study if OSA, is associated with cardiovascular diseases and if it is more 
common than other cardiovascular risk factors in this population. 
Material and Methods: This study is based on men who participated in the re-examination, in 
2014, of participants from the “The study of men born in 1943”. All participants answered 
questionnaires on health status, quality of life. They were than examined at Sahlgrenska 
University Hospital/Östra in Gothenburg, Sweden, in addition sleep-apnea screening and thumb-
EKG was performed in the participants’ homes.   
Results: A total 536 participants were included in our database, 412 of those underwent sleep-
apnea screening and were eligible for this study. 121 had obstructive sleep apnea (OSA), with 
AHI (apnea-hypopnea index) ≥ 15/h, and 191 did not.  Thus, OSA (AHI ≥ 15) is common in the 
old general population. Moreover, it is the second most common risk factor for CVDs after 
hypertension in this population. The prevalence of OSA was 29.4% in this study. BMI showed 
significance with OSA (AHI ≥ 15). We found that sleep-disordered breathing is associated with 
prevalence of hypertension in older men; however after adjustment for BMI the association was 
no-longer significant. In the subgroup of patients with severe OSA (AHI ≥30) an association 
could be found between severe OSA and atrial fibrillation even after adjustment for BMI, OR 
2.43 (1.02-5.76) 
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Conclusions: Obstructive sleep apnea (OSA) is common in the old general population. There is a 
more than two fold risk increase for having atrial fibrillation among those that had sever OSA.   
Longitudinal studies on older general population is warranted to establish whether OSA is a risk 
factor for development of atrial fibrillation as well as other cardiovascular disease for all 
individuals and not only for those in certain disease cohorts or for those with day-time sleepiness. 
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Background 
The prevalence of Obstructive sleep apnea (OSA) in the population varies greatly depending on 
what definitions for OSA that have been used. Young et al. did publish a paradigm shifting work 
in 1993 where they found that the prevalence of OSA in middle aged  (30-60 years old) 
individuals from the general population were 9% for women and 24% for men, defining OSA as 
having apnea-hypopnea index (AHI) ≥ 5 independent of daytime sleepiness1. OSA can be divided 
into mild (AHI 5-15/h), moderate (AHI 15-30/h) or severe (AHI > 30/h)2. To be called apnea the 
loss of airflow in the upper airways (nose and mouth) must have a duration of more than 10 
seconds, hypopnea on the other hand must result in a desaturation of ≥ 4% or ≥3% depending on 
what guidelines are used, for example the 2012 update of the 2007 guideline from AASM 
(American Academy of Sleep Medicine)3, 4. 
The frequent apneas during sleep in people with OSA occurs when the motor tone of the airway 
dilator muscles or the tongue (or both) is inadequate and therefore leads to the obstruction of the 
upper airway3, 5. CPAP (continuous positive airway pressure) is first line treatment. It opens the 
upper airways and thus improves the quality of sleep which leads to less subjective daytime 
sleepiness. In studies, compliance to treatment is considered to be a minimum of 4 hours CPAP 
use6-8. It is known that OSA is an independent risk factor for cardiovascular diseases such as 
stroke9, heart failure and arterial hypertension10-12 
But there is a lack of knowledge regarding obstructive sleep apnea (OSA) prevalence in older 
men, over 70-years of age, from the general population. There are two major studies, the one 
mentioned above by Young et al.1 and The Sleep Heart Health study (males ≥ 40 years)13, where 
they investigate OSA in people from the general population. But they do not only investigate men 
≥ 70 years old.  
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With this study we want to fill this gap in knowledge. Because of the large number of participants 
in this study we used ApneaLink™ (a portable sleep-screening tool) in our OSA screening14. It 
was not practically possible for us to use overnight Polysomnography (PSG). In this sub-study we 
use a cut-off at AHI ≥ 15/h for OSA. 
Usually OSA is defined both by Polysomnography (PSG) finding, e.g. AHI ≥ 5 and clinical signs 
of OSA (which includes symptoms like recurrent awakenings, fatigue or inability to focus, 
choking at night and a sensation of non-restorative sleep; two of these symptoms or excessive 
daytime sleepiness is needed for diagnosis) and is then called OSA-syndrome 3, 6, 15, 16. However, 
a minority of all that suffer from OSA (e.g. AHI ≥ 5) suffer from daytime sleepiness1.  OSA can 
also be defined by AHI ≥ 15/h without any disorders or symptoms17. 
There are two main branches of apnea, central sleep apnea (CSA) and obstructive sleep apnea 
(OSA)2. They both overlap, and we know that there is not sufficient data on the prevalence of 
central sleep apnea in the general population18. As mentioned above, if a person suffers from 
excessive daytime sleepiness and at the same time have OSA it’s called obstructive sleep apnea 
syndrome (OSAS)19, 20. In middle-aged people from the general population a connection between 
OSA and several cardiovascular diseases has been observed: hypertension21, 22; ischemic stroke 
(threefold increased risk in men with moderately severe OSA)23; coronary heart disease were men 
in the age of 40-70 years and with an AHI ≥ 30 have 68% increased risk to develop compared to 
individuals from the same population with AHI < 5)24; heart failure which males 40-70 years of 
age and AHI ≥30 have 58% increased risk to develop compared individuals from the same group  
with an AHI < 5)24;  and atrial fibrillation. According to a study from 2007 OSA is an 
independent risk factor for AF in people < 65 years of age but not for those ≥ 6525, another study 
from 2009 supports that (the mean age of the participating community-dwelling males in that 
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study were 76,4 years) because an association between CSA and AF was found but not between 
AF and OSA in older men26. The association between OSA and CVDs is strongest amongst those 
of middle-age with severe OSA (AHI > 30), but not so amongst those of older age. But according 
to an article from 2009, the Sleep Heart Health Study, sleep-disordered breathing is not, after 
adjusting for BMI, an independent risk factor for hypertension in middle-age and older men27. 
OSA can also by itself cause pulmonary hypertension10. Obesity is the largest predisposing factor 
to develop OSA, another important trigger factor is alcohol. Risk factors for developing CVDs 
are OSA11, 12, obesity28, 29, hypertension30-32, type 2 diabetes mellitus33, lack of physical activity34, 
hyperlipidemia35, high cholesterol22 and smoking22, 33. Other risk factors for CVDs according to 
the World Heart Federation are harmful use of alcohol, unhealthy diet, ethnicity, age, gender and 
family history36, 37.  
The cohort “The study of men born in 1943” is in the layup a copy of the “The study of men born 
in 1913”. Every ten years, in a cross-section of the population in Gothenburg, the mortality and 
the comorbidities are investigated in these studies: risk factors; diseases; cancer; CVDs. In 1993 
participants of “The study of men born in 1943” was examined for the first time, they had a 
follow-up in 2003 and was last examined in 2014 instead of in 2013.  
This article is based on that latest examination, which was the most comprising as of yet, and is a 
sub study with the aim to investigate the prevalence of OSA (cut-off at AHI ≥ 15) in community-
dwelling 71-year old men in Gothenburg (Sweden) and to see if OSA is associated with 
cardiovascular diseases in these participants. Another aim is to compare OSA to the prevalence of 
other risk factors for CVDs such as hypertension, type 2 diabetes mellitus, smoking and obesity.   
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Aim/specific objectives/research question 
The primary aim of this study is to measure the prevalence of obstructive sleep apnea (OSA) in 
71-year old men from the general population in Gothenburg, Sweden. The secondary aim is to 
see if OSA, is associated with cardiovascular diseases in participants over 70 years of age. The 
tertiary aim is to see if OSA is more common than other cardiovascular risk factors in this study 
population. 
We hypothesizes that OSA is more common in this older population than what have been 
observed in younger cohorts1. Moreover, we assume that OSA is associated with cardiovascular 
disease (e.g. hypertension atrial fibrillation, coronary artery disease and heart failure) in this older 
population. The following research questions  were therefore stipulated: ”What is the prevalence 
of obstructive sleep apnea in 71-year old men from the general population?”, ”Is OSA associated 
with cardiovascular disease?” and “Is OSA more common than other cardiovascular disease risk 
factors?”. 
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Material and Methods 
Study population 
This sub-study is based on the data collected during the third follow-up examination, in 2014, of 
the participants of the main study “The study of men born in 1943” which started in 1993. In 
1993, a random sample from the population, in Gothenburg (Sweden), was selected.  The criteria,  
for participation in the study, were  male gender, date of birth during 1943 (50 years of age) and a 
resident of Gothenburg. Every second person fulfilling this criteria were randomly selected and 
invited to participate in the study, a total of 1460 men were summoned. Of those 6 was diseased 
and 1 had immigrated and they were therefore excluded. A total of 1453 were thus eligible for 
part taking in the study at the first visit in 1993, of those 656 people declined or did not respond 
to the first summon. Thus, 54.9% (n = 798) participants were examined in 1993. A re-
examination was performed in 2014. Of the 798 participants examined in 1993 15.2% or 121 had 
diseased 2014 and 3.0% or 24 people had emigrated, had an unknown address, or had changed 
sex (n = 1) during the follow-up period. Thus, 653 men were invited to the reexamination, the 
criteria for participation was that they had been examined in 1993. Of those 6.6% (n =43) people 
did not want to, or could not participate and 11.3 % (n =74) people did not answer the call for 
reexamination, consequently a total number of 536 participants, 67.2% of those originally 
examined were reexamined between 2014-05-14 and 2014-12-15. 
Examinations 
Before physical examination each participants received three different questionnaires: a WHO-
form about physical activity, smoking habits, chest pain and levels of stress; a questionnaire 
addressing medical history and the third questionnaire focused on eating habits. The research 
division at Sahlgrenska University Hospital Östra in Gothenburg (Sweden) performed all the 
examinations. The participants born earliest during the year were summoned first. The 
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participants should not have eaten or used any tobacco products for at least four hours prior to the 
examination.  The examination included collection of venous blood samples (S-cholesterol, S-
triglycerides, HDL-cholesterol, LDL-cholesterol, fasting-plasma-glucose, NT-proBNP), 
echocardiography, EKG, anthropometric data (length, hip, waist, weight, upper right arm), blood 
pressure, heart and lung auscultation, checking for signs of  heart failure, angina pectoris, 
intermittent claudication and a part of Berg’s balance scale test. The only examinations not 
performed directly were the sleep apnea screening (offered to participants without known sleep 
apnea) and thumb EKG.  The participants received (after the examination at the hospital) a 
portable ApneaLink™ Plus (Resmed, San Diego, Ca, USA) for the apnea screening and thumb 
EKG-machine (Zenicor-EKG, Zenicor Medical Systems AB, Stockholm, Sweden) to take home. 
(For the first two months we used ApneaLink™ which cannot differentiate between CSA and 
OSA.) The participants who accepted the ApneaLink™ Plus screening used it for one home-
night-sleep were also answering a questionnaire regarding sleep and sleep disorders, as well as 
the Epworth Sleepiness Scale. The thumb EKG was used two times a day for two weeks. It was 
first after the participants came back with the equipment that the data stored in them could be 
read. The examinations were carried out by healthcare professionals; this included cardiologists, 
doctors, a nurse, an assistant nurse and two medical school students (five years into their 
education). The blood samples were analyzed at Sahlgrenska University Hospital in Gothenburg 
(Sweden). 
Data collection procedures 
All the data from the eleven forms used in the main study were entered into a Microsoft Excel 
2010 document and proofread by medical school students (S.G. and H.H.H). All the original 
forms are stored at Sahlgrenska University Hospital Östra in Gothenburg, Sweden. 
10 
 
Bias 
Although the option to participate in the main study for the first time in 1993 was given to men 
born in 1943 and at the time of the study start lived in Gothenburg many of them declined. A 
major similar study from the general population has shown that there is a large difference in 
participation rates between people from areas of low and high socio-economic status, only 37% 
participation rate regarding the low socio-economic status area compared to 67% from the high 
socio-economic status area38. We suspect that many of the people who accepted our invitation to 
participate in the main study in 1993 were those of a relatively higher socioeconomic status and 
better health. It is possible that this can be a source of selection bias.  
Variables 
The variables used in this sub-study are taken from the forms mentioned above. The main out-
come variable is OSA, defined using an AHI cut-off   ≥ 15/h.  The cut-off used was the cut-off 
for moderate OSA, which also is the level required to obtain CPAP treatment at Sahlgrenska 
University Hospital. Furthermore, the ApneaLink™ has a god sensitivity and specificity for 
detecting OSA at this AHI cut-off14 . Other variables used in the analyses are hypertension, type 
2 diabetes mellitus, smoking and obesity. Age and gender are not relevant in the analyses since 
all the participants were born in 1943 and all are males. Body max index (BMI) ≥ 30 kg/m2 
equals obesity and the formula used to calculate BMI was bodyweight divided by height squared. 
Hypertension is defined as a systolic blood pressure of ≥140 and/or a diastolic blood pressure of 
≥90, and/or if a doctor has diagnosed high blood pressure and/or if a participant is taking 
medication for hypertension. 
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Statistical methods 
Linear regression analysis was used to analyze correlations between continuous variables while 
logistic regression analysis was used to analyze correlations between categorical variables. All p-
values below 0.05 were considered significant. The Statistical Package for Social Sciences 
version 22.0 for the Windows system (SPSS Inc., Chicago, IL) was used to perform all the 
statistical analysis. For comparison of the groups, Independent sampled student T-test and Cross 
Tabulation were used. Chi-square test was applied for comparison of the categorical variables. 
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Ethics 
All the participants in this study were part of it on their own free will. They could at any given 
time discontinue their participation in the study. All participants were given written and oral 
information and signed informed consent.  If a disease or symptom were detected during the 
examinations it was addressed according to clinical routines at the hospital.  
This study complies with the UNESCO´s “Universal Declaration on Bioethics and Human 
Rights”39 and the World Medical Association’s “Declaration of Helsinki ”40, and the study 
protocol was approved by the Ethics Committee of the Medical Faculty of the University of 
Gothenburg. 
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Results 
We invited 653 participants to our main study “The study of men born in 1943”. Of those 536 
participants came to be examined and were included in our database (Figure 1). 412 had filled in 
the required questionnaires and participated in sleep apnea screening and were thus eligible for 
this sub-study. 121 had obstructive sleep apnea (OSA), with cutoff at AHI (apnea-hypopnea 
index) ≥ 15/h, and 291 did not. 
 
Table 1: Of all the variables, except “AHI” and “ODI”, only “Obesity”, “BMI”, “, “Heart failure” 
and “Hypertension” showed a significant difference between the groups.  
The univariate logistic regression analysis shows that the univariate variables “BMI”, “Obesity” 
and  “Hypertension” were associated with OSA (Table 2) in this cross-sectional sub-study.  In the 
multivariate logistic regression analysis (Table 2) only BMI showed a significant association with 
OSA.  
The prevalence of conditions and diseases in the study population: 
As shown in Figure 2, OSA is highly prevalent in the cohort. Moreover it has a higher prevalence 
in the cohort than most risk factor for CVDs and it is more common than atrial fibrillation, 
myocardial infarction, angina, chronic obstructive pulmonary disease (COPD) and heart failure.  
Figure 3 shows the occurrence of CVDs and risk factors of those with OSA, cutoff AHI ≥ 15. 
When looking at only the OSA population there is a 10.7% increase in the prevalence of 
hypertension compared to the study population who do not have OSA (Figure 4). A 19.5% 
increase regarding obesity. There is also an increase in atrial fibrillation (6.1%), diabetes (4.0%), 
myocardial infarction (3.5%), angina (1.8%) and heart failure (3.7%). But there is a decrease in 
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the prevalence of stroke (3.8%), current smoking (0.3%) and COPD (1.9%) compared to the no-
OSA population. 
Figure 4 shows the occurrence of CVDs and risk factors of those who do not have OSA. As 
stated above it is more common with stroke, COPD and current smoking compared to the study 
population that has OSA (Figure 3). 
Figure 5 shows the different AHI levels in the study population n=412. 138 people or 33.5% were 
within the AHI interval 0-4.99. 153 or 37.1% in AHI 5-14.99. 85 or 20.6% in AHI 15-29.99. 36 
or 8.7% had AHI ≥ 30. ApneaLink™ is not verified regarding AHI < 15 and thus we will not use 
the intervals below the cut-off for this study. A total of 70.6% of the participants had AHI below 
15 and 29.4% had above.  
Table 3 shows the characteristics of the study population with severe obstructive sleep apnea. 
“Obesity”, “BMI”, “Hypertension” and “Atrial fibrillation” shows significance with severe OSA. 
Table 4 shows variables associated with severe obstructive sleep apnea. The univariate analysis 
shows significance between “Obesity”, “BMI”, “Atrial fibrillation” and “Hypertension”. In the 
multivariate analysis only BMI and atrial fibrillation remained significant with severe OSA. A 
2.4 odds ratio regarding “Atrial fibrillation” could be seen. 
Figure 6 shows the occurrence of CVDs and risk factors of those with severe OSA, cutoff AHI ≥ 
30. The prevalence of hypertension in this study population (n = 36) is very high (97.2%). The 
occurrence of obesity, atrial fibrillation and diabetes is also very common.  
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Discussion 
In this sample of 71-year old men we have found that OSA (AHI ≥ 15) is common in the old 
general population. Moreover, it is the second most common risk factor for CVDs after 
hypertension. An association could be found between severe OSA and BMI and atrial fibrillation 
(Table 4). Table 4 also shows that it is 2.4 times increased risk to have atrial fibrillation if you 
have severe OSA. The prevalence of OSA is 29.4% among old men (71 years) in this study. A 
flow chart of the participants shows that 412 of them met the requirements needed to be a part of 
this sub-study (Figure 1). The flow chart lists various reasons why participants were excluded. 
Maybe these exclusions affected the prevalence of moderate to severe OSA in the study 
population. Young et al1 showed a prevalence of OSA by 24% (cut-off AHI ≥ 5) among males in 
their study population which consisted of middle-aged (30-60 years old) individuals from the 
general population. It is important to note that we used a different cut-off (AHI ≥ 15) for OSA 
than they did in the study mentioned above.  
We found that among 71-year-old males OSA is not only more common than typical CVDs risk 
factors such as obesity, type 2 diabetes mellitus and smoking but also more prevalent than atrial 
fibrillation, myocardial infarction, angina pectoris and chronic obstructive pulmonary disease 
(COPD). 
The multivariate logistic regression analysis in Table 2 shows that there was only significance in 
the association between OSA and BMI. The results in this study is similar as what was found in 
the Sleep Heart Health Study 2009, that sleep-disordered breathing not is, after adjusting for 
BMI, an independent risk factor for hypertension in older men27. But in their study there wasn’t 
even an association in middle-aged men.  
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Table 1 support our hypothesis, that obstructive sleep apnea is more common in this older 
population compared to cohorts with younger people1. And we even used a much higher cut-off 
at AHI ≥ 15. The hypothesis is therefore relevant, a new hypothesis could be “Is the prevalence 
of OSA in the general population age dependent and is it clinically relevant after adjusting for 
age?”. 
It was more common that the participants with OSA had hypertension, obesity, diabetes, higher 
BMI, higher ESS score, atrial fibrillation, heart failure, myocardial infarction, angina pectoris and 
cancer compared to the “no OSA group”. More participants of the OSA group had also in greater 
extent undergone bypass surgery and PCI (Percutaneous coronary intervention). Although most 
of these differences between the two groups were not significant. 
Even though the awareness of OSA has increased, compared to other cardiovascular risk factors 
such as diabetes it is still an underestimated condition and its association with cardiovascular 
diseases needs to be further explored especially in non-sleep laboratory cohorts.  
Sleep is an important part of life, some sleep more and some less, and maybe an early detection 
of OSA in people with symptoms (through sleep-screening at their homes) could lead to health 
benefits through early treatments and therefore lowering the total costs of healthcare which in the 
end mean socio-economic gains.   
The strength of this study lies in the fact that the study population is very homogenous (same sex 
and of the same age) and from the general population, unlike many other studies in which the 
study population consists of hospital patients. 
A limitation to this study is that the study population could be a source of selection bias38. Why 
that is could have its answer in that people of a relatively higher socioeconomic class tends to 
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participate in this kind of studies. Maybe they also take care of themselves better, read more 
about different lifestyle related diseases and what to do to avoid them and that they are more 
positive to participate in studies like this. Because they participate in studies who offer health 
care examinations for free there is an opportunity for discovery of serious symptoms and diseases 
by chance. The participants therefore receive treatment for serious symptoms and diseases much 
earlier than those who choose not to participate; treatments that in many cases could be directly 
lifesaving. Another limitation to this study is that we did not use overnight Polysomnography 
(PSG) in the detection of OSA. PSG is more sensitive than ApneaLink™ at lower AHI levels14. 
If we had used PSG and cut-off for OSA at AHI ≥ 5 the prevalence of OSA would probably have 
been higher. 
Conclusion 
Obstructive sleep apnea (OSA) is common in the old general population, 29.4%.  BMI is 
associated with OSA (AHI ≥ 15). There is a more than two fold risk increase for having atrial 
fibrillation among those that had sever OSA. As a risk factor for CVDs OSA was the second 
most common after hypertension. A possible association could be found between OSA and 
hypertension in this study, but after adjusting for BMI the association was no longer significant.  
Longitudinal studies on older general population is warranted to establish whether OSA is a risk 
factor for development of atrial fibrillation as well as other cardiovascular disease for all 
individuals and not only for those in certain disease cohorts or for those with day-time sleepiness. 
More questionable is whether OSA is associated to most of the CVDs. 
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Populärvetenskaplig sammanfattning 
Sömnapné eller andningsuppehåll då man sover är mycket vanligt hos äldre personer i 
befolkningen och deltagarna i denna understudie tillhörde denna kategori. Den sortens sömnapné 
som vi här berör är den obstruktiva eller tilltäppande/hindrande sömnapnén. Precis som man hör 
på namnet innebär detta en tilltäppning av luftvägarna, i detta fall av svalget då tungan under 
sömnen glider bakåt och på så sätt hindrar luftflödet under andningen. Andningsrörelserna 
fortsätter men otillräckligt med syrerik luft åker ned och fyller lungorna. Det kan leda till att man 
inte blir utsövd och därför är trött under dagen samt har koncentrationsproblem. Sömnapné är 
vanligare hos feta individer och hos de som brukar alkohol innan sänggående. Alkoholen gör att 
muskler i svalget slappnar av vilket kan leda till ett trängre utrymme för luften att passera. Om 
man har tillräckliga besvär kan man få behandling med en så kallad CPAP-apparat, CPAP  är en 
engelsk förkortning på Continuous Positive Airway Pressure vilket är kontinuerlig 
övertrycksbehandling på svenska.  
Många artiklar har tidigare skrivit att sömnapné i sig självt leder till för högt blodtryck, vi fann att 
ett sådant samband i den äldre manliga delen av befolkningen möjligen kan finnas. Med äldre 
menar vi personer över 70 år. Vi kunde inte finna något samband mellan sömnapné och de flesta 
av hjärt- och kärlsjukdomarna.  Men hos de med allvarlig obstruktiv sömnapné fann vi ett 
samband med BMI (Body Mass Index) och förmaksflimmer. 
Vi fann att sömnapné inte bara är mer vanligt förekommande än fetma och rökning utan också 
mer vanligt än förmaksflimmer, hjärtinfarkt, hjärtsvikt, kronisk obstruktiv lungjukdom och 
diabetes. Det man kan fundera på är om sömnapné är en del i det naturliga åldrandet och vilka 
sjukdomar detta kan leda till hos den drabbade.  
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Sömnen är ett mycket viktigt område då vi alla tillbringar en stor del av livet sovandes, andra mer 
och andra mindre.  I samband med att vi blir allt äldre och fetare kommer förmodligen fler 
personer drabbas av sömnapne. Därför tycker vi att konsekvenserna av andningsuppehåll under 
sömnen och dess samband med hjärt- och kärlsjuklighet borde utredas vidare.   
Kanske kan en tidig upptäckt av sömnapné hos folk med symptom leda till hälsovinster för den 
enskilde genom att de får tidig behandling vilket i sin tur skulle leda till samhällsekonomiska 
vinster genom att de totala sjukvårdskostnaderna då sjunker. 
Vi tycker att denna studien är viktig eftersom den visar hur vanligt sömnapné är hos äldre män 
från den vanliga befolkningen.  
Undersökningarna av deltagarna ägde rum på Sahlgrenska Universitetssjukhuset/Östra mellan 
2014-05-14 och 2014-12-15. Deltagarna fick med sig hem en liten apparat (heter ApneaLink™) 
som mäter andningsuppehåll och en annan apparat som mäter pulsen genom att man fäster den på 
tummen. 
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Tables and Figures 
 
  
653 participants were invited to examination/screening 
74 did not answer 
43 declined 
536 participants were examined and were included in the database 
412 participants filled out the required questionnaires and participated in sleep apnea 
screening 
Participants who did not participate in Apnea-Link screening and reason 
why: 
32 Evaluation time too short 
29 Declined 
29 Missing data 
16 CPAP treatment or known apnea 
8 No nasal cannula 
8 Not performed 
2 Language difficulties 
 
121 had obstructive sleep apnea 
Figure 1. Flow chart of the participants 
291 did not have obstructive sleep apnea 
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Table 1. Characteristics of study population undergoing sleep apnea screening with ApneaLink 
Variable All patients (n=412) OSA (n = 121) No OSA (n = 291) P-value 
Obesity, % 18.4 32.2 12.7 <0.001 
BMI, kg/m2 27.0 ± 3.8  28.4 ± 4.2 26.4 ± 3.5 <0.001 
ESS score 5.5 ± 4.1 6.0 ± 4.5 5.3 ± 3.9 0.117 
AHI, no./h 11.7 ± 11.9 26.8 ± 11.3 5.4 ± 3.7 <0.001 
ODI, no./h 9.9 ± 10.2 20.8 ± 12.3 5.5 ± 4.3 <0.001 
Current smokers, % 6.8 6.6 6.9 0.924 
Hypertension, % 82.5 90.1 79.4 0.009 
Atrial fibrillation, % 11.4 15.7 9.6 0.077 
Diabetes mellitus, % 12.9 15.7 11.7 0.267 
Stroke, % 8.5 5.8 9.6 0.203 
Depression, % 10.4 9.9 10.7 0.824 
Heart failure, % 3.2 5.8 2.1 0.049 
Myocardial infarction, % 10.0 12.4 8.9 0.285 
Angina pectoris, % 5.3 6.6 4.8 0.459 
COPD, % 4.6 3.3 5.2 0.415 
Cancer, % 19.7 21.5 18.9 0.547 
Asthma, % 4.9 3.3 5.5 0.346 
Bypass surgery, % 4.6 5.0 4.5 0.829 
PCI, % 8.5 10.7 7.6 0.291 
Definition of abbreviations: OSA = obstructive sleep apnea with cutoff at AHI ≥ 15/h; AHI = apnea-
hypopnea index; BMI = body mass index; ESS = Epworth Sleepiness Scale; ODI = oxygen desaturation 
index; PCI = Percutaneous coronary intervention; Means ± SD (standard deviation) are continuous 
variables expressed as. 
 
 
Table 2. Variables associated with obstructive sleep apnea in study population* 
 OR 95% CI P-value 
Univariate analysis    
   Obesity 3.27 1.95-5.46 <0.001 
   BMI, kg/m2 1.14 1.08-1.21 <0.001 
   Heart failure 2.92 0.96-8.87 0.059 
   Hypertension 2.36 1.22-4.57 0.011 
Multivariate analysis    
   BMI, kg/m2 1.13 1.06-1.20 <0.001 
   Hypertension 1.78 0.90-3.51 0.098 
Definition of abbreviations: OR = odds ratio; CI; confidence interval; BMI = body mass index. *Study 
population: n = 412. 
 
  
25 
 
  
Figure 2. Occurrence of CVDs, riskfactors for CVDs including OSA in study population (n = 412). Definition 
of abbreviations: CVDs = cardiovascular diseases; OSA = obstructive sleep apnea with cutoff at AHI ≥ 15; 
AHI = apnea-hypopnea index; HTN = Hypertension; MI = Myocardial infarction; AF = Atrial fibrillation; 
COPD = Chronic obstructive pulmonary disease; HF = Heart Failure. 
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 Figure 3. Occurrence of CVDs, risk factors for CVDs in study population (n = 121) that have OSA. Definition 
of abbreviations: CVDs = cardiovascular diseases; OSA = obstructive sleep apnea with cutoff at AHI ≥ 15; 
AHI = apnea-hypopnea index; HTN = Hypertension; MI = Myocardial infarction; AF = Atrial fibrillation; 
COPD = Chronic obstructive pulmonary disease; HF = Heart Failure. 
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 Figure 4. Occurrence of CVDs, risk factors for CVDs in study population (n = 291) that do not have OSA. 
Definition of abbreviations: CVDs = cardiovascular diseases; OSA = obstructive sleep apnea with cutoff at 
AHI ≥ 15; AHI = apnea-hypopnea index; HTN = Hypertension; MI = Myocardial infarction; AF = Atrial 
fibrillation; COPD = Chronic obstructive pulmonary disease; HF = Heart Failure. 
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 Figure 5. AHI levels in study population n=412. Definition of abbreviations: AHI = apnea-hypopnea index.  
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Table 3. Characteristics of study population with severe obstructive sleep apnea 
Variable All patients (n=412) Severe OSA (n = 36) No severe OSA (n = 376) P-value 
Obesity, % 18.4 41.7 16.2 <0.001 
BMI, kg/m2 27.0 ± 3.8  29.9 ± 5.0 26.7 ± 3.6 <0.001 
ESS score 5.5 ± 4.1 6.4 ± 4.4 5.5 ± 4.1 0.202 
AHI, no./h 11.7 ± 11.9 41.0 ± 10.3 8.9 ± 7.5 <0.001 
ODI, no./h 9.9 ± 10.2 31.5 ± 15.9 8.0 ± 6.8 <0.001 
Current smokers, % 6.8 8.3 6.6 0.701 
Hypertension, % 82.5 97.2 81.1 0.015 
Atrial fibrillation, % 11.4 25.0 10.1 0.007 
Diabetes mellitus, % 12.9 22.2 12.0 0.079 
Stroke, % 8.5 5.6 8.8 0.508 
Depression, % 10.4 16.7 9.8 0.201 
Heart failure, % 3.2 5.6 2.9 0.388 
Myocardial infarction, % 10.0 13.9 9.6 0.409 
Angina pectoris, % 5.3 8.3 5.1 0.403 
COPD, % 4.6 0.0 5.1 0.167 
Cancer, % 19.7 19.4 19.7 0.973 
Asthma, % 4.9 2.8 5.1 0.544 
Bypass surgery, % 4.6 8.3 4.3 0.265 
PCI, % 8.5 8.3 8.5 0.971 
Definition of abbreviations: Severe OSA = obstructive sleep apnea with cutoff at AHI ≥ 30/h; AHI = apnea-
hypopnea index; BMI = body mass index; ESS = Epworth Sleepiness Scale; ODI = oxygen desaturation 
index; PCI = Percutaneous coronary intervention; Means ± SD (standard deviation) are continuous 
variables expressed as. 
 
 
Table 4. Variables associated with severe obstructive sleep apnea in study population* 
 OR 95% CI P-value 
Univariate analysis    
   Obesity 3.69 1.80-7.56 <0.001 
   BMI, kg/m2 1.21 1.11-1.31 <0.001 
   Atrial fibrillation 2.97 1.30-6.77 0.010 
   Hypertension 8.15 1.10-60.47 0.040 
Multivariate analysis    
   BMI, kg/m2 1.18 1.09-1.29 <0.001 
   Atrial fibrillation 2.43 1.02-5.76 0.044 
   Hypertension 4.89 0.64-37.17 0.125 
Definition of abbreviations: OR = odds ratio; CI; confidence interval; BMI = body mass index. *Study 
population: n = 412. 
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 Figure 6. Occurrence of CVDs, risk factors for CVDs in study population (n = 36) that have severe OSA. 
Definition of abbreviations: CVDs = cardiovascular diseases; OSA = obstructive sleep apnea with cutoff at 
AHI ≥ 15; AHI = apnea-hypopnea index; HTN = Hypertension; MI = Myocardial infarction; AF = Atrial 
fibrillation; COPD = Chronic obstructive pulmonary disease; HF = Heart Failure. 
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